SEC Contract Filing

Filing Date: 2021-03-16

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>itrm-ex101_7.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
itrm-ex101_7.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EXHIBIT 10.1</font></p>
<p style="text-align:center;margin-top:3pt;line-height:12pt;margin-bottom:0pt;margin-left:24.07%;margin-right:23.96%;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-top:3pt;line-height:12pt;margin-bottom:0pt;margin-left:24.07%;margin-right:23.96%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">I<font style="font-size:9pt;">TERUM </font>T<font style="font-size:9pt;">HERAPEUTICS PLC</font></p>
<p style="text-align:center;line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:24.07%;margin-right:23.96%;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:11pt;font-style:normal;text-transform:none;">Amended and Restated<font style="font-family:Times New Roman;font-variant: normal;"> N</font><font style="font-size:9pt;font-family:Times New Roman;font-variant: normal;">ON</font><font style="font-family:Times New Roman;font-variant: normal;">-E</font><font style="font-size:9pt;font-family:Times New Roman;font-variant: normal;">MPLOYEE </font><font style="font-family:Times New Roman;font-variant: normal;">D</font><font style="font-size:9pt;font-family:Times New Roman;font-variant: normal;">IRECTOR </font><font style="font-family:Times New Roman;font-variant: normal;">C</font><font style="font-size:9pt;font-family:Times New Roman;font-variant: normal;">OMPENSATION </font><font style="font-family:Times New Roman;font-variant: normal;">P</font><font style="font-size:9pt;font-family:Times New Roman;font-variant: normal;">OLICY</font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.24%;margin-right:1.04%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Members of the board of directors (the &#8220;<font style="font-weight:bold;font-style:italic;">Board</font>&#8221;) of Iterum Therapeutics plc (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) shall be eligible to receive the cash and equity compensation for their service on the Board and any committee of the Board (a &#8220;<font style="font-weight:bold;font-style:italic;">Committee</font>&#8221;) as set forth in this Non-Employee Director Compensation Policy (this &#8220;<font style="font-weight:bold;font-style:italic;">Policy</font>&#8221;). The cash compensation and equity grants described in this Policy shall be paid or be made, as applicable, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a &#8220;<font style="font-weight:bold;font-style:italic;">Director</font>&#8221;), unless such Director declines the receipt of such cash compensation or equity grants by written notice to the Company. No separate compensation for Board service shall be paid to any member of the Board who is an employee of the Company or any parent or subsidiary of the Company. This Policy shall remain in effect until it is amended or rescinded by further action of the Board.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.24%;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Cash Compensation</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.24%;margin-right:1.46%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commencing March 11, 2021, each Director shall be eligible to receive the annual cash retainers described below. The annual cash retainers will be paid in four equal quarterly installments in arrears, and will be fully vested and earned when paid.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.24%;margin-right:1.67%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Director shall be eligible to receive an annual cash retainer of $35,000 for service on the Board. The non-executive chairperson of the Board shall be eligible to receive an additional annual cash retainer of</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:1.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$27,500 for such service.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-left:1.24%;margin-right:2.5%;text-indent:0%;font-fami